CLOSE X
GO

Bajaj Finserv Healthcare Fund-Reg(G)

very highequitypharma & health care
9.13 0.02(0.23%) NAV as on 07 Apr 2026
-2.6 % 1 M
5.45 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.39

As on 28 Feb, 2026
age-icon Age :

1 yrs 3 m

Since 27 12 ,2024
exit_load Exit Load :

1%

aum AUM :

300.45 Crs

lock_in Lock-in :

1% on or before 3M, Nil after 3M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.62

Min_Investment Min. Investment :

SIP 1000 & Lumpsum 500

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Nimesh Chandan,Sorbh Gupta,Siddharth Chaudhary

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2026
Others 5.22 %
Equity 94.78 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.41 %
Divi's Laboratories Ltd.8.95 %
Apollo Hospitals Enterprise Ltd.6.75 %
Aurobindo Pharma Ltd.6.63 %
Piramal Pharma Ltd.5.69 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs61.43
Hospital & Healthcare Services18.34
Miscellaneous3.84
Household & Personal Products2.49
Consumer Food2.46
See All Sectors

5-YEARS HISTORY

Financial Year2024-20252025-2026
NAV in Rs (as on 31-Mar-2026)9.089.07
Net Assets(Rs Crores) (as on 31-Mar-2026) 307.40 314.74
Scheme Returns(%)(Absolute)-9.211.18
B'mark Returns(%)(Absolute)NANA
Category Rank95/10240/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Bajaj Finserv Healthcare Fund-Reg(G)Very HighEquity9.130.02(0.23%)NAV As on 07 Apr, 202627-Dec-2024Inception Date300.45AUM In Cr.5.45%1YNA%3YNA%5Y-6.89%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity36.69-0.01(-0.03%)NAV As on 07 Apr, 202613-Jul-2018Inception Date6,801.16AUM In Cr.6.69%1Y24.54%3Y15.50%5Y18.29%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity29.950.10(0.34%)NAV As on 07 Apr, 202610-Jul-2019Inception Date854.04AUM In Cr.7.42%1Y21.77%3Y12.51%5Y17.65%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors